OKUR
NASDAQ
$4.12
Reneo Pharmaceuticals Inc - Class A (OKUR)
OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company is headquartered in Boulder, Colorado.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $21 (+409.71%)
Market Cap
$59M
FCF 5Y CAGR
+22.82%
Free Cash Flow Yield
-87.63%
Beta (5Y)
0.98
Price Chart
Valuation
Market Cap$59M
P/B1.05
Profitability
EBITDA-$63M
EPS-$4.41
Financial Health
Free Cash Flow Yield-87.63%
Growth & Risk
FCF 5Y CAGR+22.82%
Beta (5Y)0.98
Sharpe Ratio1.05